Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shuster

Showing results (401-410 of 513) with videos related to

Pageof 52
Sort By:
Journal of Pediatric Hematology/Oncology|January 1, 1997
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)L S Frankel, J Ochs, J J Shuster, et al.
Blood|September 1, 1992
Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group studyV M Whitehead, M J Vuchich, S J Lauer, et al.
Lupus|September 24, 2005
High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular riskE V Barnes, S Narain, A Naranjo, et al.
Cancer|February 15, 1991
Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group studyA H Ragab, A Abdel-Mageed, J J Shuster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group studyM J Borowitz, J J Shuster, C I Civin, et al.
Cancer|May 1, 1993
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyS J Lauer, B M Camitta, B G Leventhal, et al.
Progress in Clinical and Biological Research|January 1, 1994
Screening for neuroblastoma (NB) in North America: the Quebec ProjectW G Woods, B Lemieux, J M Leclerc, et al.
The New England Journal of Medicine|April 5, 2002
Screening of infants and mortality due to neuroblastomaWilliam G Woods, Ru-Nie Gao, Jonathan J Shuster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group studyM M Wofford, S D Smith, J J Shuster, et al.
Arthritis and Rheumatism|September 18, 2003
A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in miceKim W McIntyre, David J Shuster, Kathleen M Gillooly, et al.
Pageof 52

Showing results (401-410 of 513) with videos related to

Sort By:
Pageof 52
Journal of Pediatric Hematology/Oncology|January 1, 1997
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)L S Frankel, J Ochs, J J Shuster, et al.
Blood|September 1, 1992
Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group studyV M Whitehead, M J Vuchich, S J Lauer, et al.
Lupus|September 24, 2005
High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular riskE V Barnes, S Narain, A Naranjo, et al.
Cancer|February 15, 1991
Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group studyA H Ragab, A Abdel-Mageed, J J Shuster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group studyM J Borowitz, J J Shuster, C I Civin, et al.
Cancer|May 1, 1993
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyS J Lauer, B M Camitta, B G Leventhal, et al.
Progress in Clinical and Biological Research|January 1, 1994
Screening for neuroblastoma (NB) in North America: the Quebec ProjectW G Woods, B Lemieux, J M Leclerc, et al.
The New England Journal of Medicine|April 5, 2002
Screening of infants and mortality due to neuroblastomaWilliam G Woods, Ru-Nie Gao, Jonathan J Shuster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group studyM M Wofford, S D Smith, J J Shuster, et al.
Arthritis and Rheumatism|September 18, 2003
A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in miceKim W McIntyre, David J Shuster, Kathleen M Gillooly, et al.
Pageof 52